Pharmaceutical - Ireland

Filter

Current filters:

Ireland

Popular Filters

Shire gets priority review for its Vyvanse sNDA in binge eating from FDA

Shire gets priority review for its Vyvanse sNDA in binge eating from FDA

15-09-2014

Ireland-headquartered drugmaker Shire has received acceptance for its filing with priority review for…

AbbVieIrelandNeurologicalPharmaceuticalRegulationShireVyvanse

Norgine sells certain rights for Camcolit and Somnite to Essential Pharma

11-09-2014

Netherlands-headquartered independent drugmaker Norgine has agreed to sell all rights in the UK for Somnite…

Essential PharmaIrelandLicensingNeurologicalNorginePharmaceuticalUK

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

Actavis reports 2nd-qtr revenues increase by over a third

Actavis reports 2nd-qtr revenues increase by over a third

05-08-2014

Ireland-headquartered generics major Actavis has reported a 34% boost in revenue in the second quarter…

ActavisActavis PharmaBusiness FinanceBusiness FinanceFinancialIrelandPharmaceutical

Janssen’s simeprevir for hepatitis C shows good efficacy in Phase II trial

Janssen’s simeprevir for hepatitis C shows good efficacy in Phase II trial

31-07-2014

Some 92% of genotype 1 chronic hepatitis C virus (HCV) adult patients treated with US health care giant…

Anti-viralsGilead SciencesIrelandJanssenPharmaceuticalResearchsimeprevirsofosbuvir

Ireland to make more drugs available over the counter

Ireland to make more drugs available over the counter

20-07-2014

Last week, Ireland’s Health Products Regulatory Authority (HPRA) published a list of 12 active substances…

Health Products Regulatory AuthorityIrelandPharmaceuticalRegulation

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

18-07-2014

Ireland-headquartered drugmaker Shire, which has just accepted an increased $54 billion bid from the…

AbbVieFinancialIrelandPharmaceuticalShire

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Stada Arz acquires Flexitol rights for UK and Ireland

Stada Arz acquires Flexitol rights for UK and Ireland

10-07-2014

Thornton & Ross, the UK subsidiary of German generic and branded drugmaker Stada Arzneimittel, has purchased…

DermatologicalsFlexitolIrelandMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & RossUK

AbbVie opens expanded manufacturing facility in Ireland

AbbVie opens expanded manufacturing facility in Ireland

03-06-2014

The chairman and chief of US drugmaker AbbVie, Richard Gonzalez, accompanied by other senior executives,…

AbbVieAnti-viralsFinancialIrelandPharmaceuticalProduction

Back to top